U.S. Markets open in 37 mins

Where's The Tylenol? J&J Disappoints And Frustrates

Johanna Bennett

Shares of J&J were hammered today after the health-care giant delivered consensus-beating fourth quarter financial results and full-year 2018 guidance. The numbers below the surface chased off investors. Here’s why.